Physician profile
Raffaella Buffolino
NPI 1871727024
$9,817.14
in general payments reported to CMS, 2019-2025
19 companies · $1,333 in 2025
The $1,333 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.44 · 2020: $22.42 · 2021: $957 · 2022: $1,248 · 2023: $2,974 · 2024: $3,234 · 2025: $1,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,469 · Food and Beverage: $2,992 · Consulting Fee: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,468.89 |
| Food and Beverage | $2,992.29 |
| Consulting Fee | $1,080.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,361.18 | 2019-2025 | Regranex, Grafix Pl, Grafix |
| Kerecis Limited | $2,738.68 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Polaris Technology Solutions LLC | $1,200.00 | 2022 | |
| Treace Medical Concepts, INC. | $1,078.20 | 2021-2025 | |
| Acumed LLC | $538.00 | 2021 | |
| Integra Lifesciences Corporation | $168.32 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nevro Corp. | $137.28 | 2024 | Senza |
| Acera Surgical, INC. | $133.29 | 2025 | Restrata Wound Matrix |
| Access Pro Medical, LLC | $129.54 | 2025 | Matriderm |
| Stryker Corporation | $67.35 | 2023 | Hoffmann |
| Paragon 28, INC. | $60.55 | 2024 | |
| Linvatec Corporation | $45.45 | 2024 | Biobrace 23mm |
| Orthofix Medical, INC. | $32.59 | 2024 | Physio-Stim |
| Cumberland Pharmaceuticals, INC. | $30.11 | 2024 | Caldolor |
| Organogenesis INC. | $26.66 | 2025 | Puraply Wound Matrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $22.42 | 2020 | |
| Mimedx Group, INC. | $19.08 | 2024 | |
| Paratek Pharmaceuticals, INC. | $16.19 | 2025 | Nuzyra |
| Melinta Therapeutics, LLC | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raffaella Buffolino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.